PP
CRNX icon

Paloma Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Paloma Partners’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,369
Closed -$210K – 1241
2019
Q4 		$210K Buy
+8,369
New +$210K ﹤0.01% 1647